racemetirosine has been researched along with Abdominal Neoplasms in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Abdominal Neoplasms: New abnormal growth of tissue in the ABDOMEN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caballero, R | 1 |
| Pirmohamed, R | 1 |
| Wright, JA | 1 |
1 other study available for racemetirosine and Abdominal Neoplasms
| Article | Year |
|---|---|
Use of alpha-methyl-tyrosine for refractory hypertension in a child with neuroblastoma.
Topics: Abdominal Neoplasms; alpha-Methyltyrosine; Blood Pressure; Combined Modality Therapy; Dose-Response | 1992 |